Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 95 entries
Sorted by: Best Match Show Resources per page
'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association

Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis JA, Shaw JE, Skinner T, Speight J.
PMID: 34465005
Diabet Med. 2022 Feb;39(2):e14681. doi: 10.1111/dme.14681. Epub 2021 Sep 04.

AIMS: This qualitative study aims to explore beliefs, attitudes and experiences of injectable glucagon-like-peptide-1 receptor agonists (GLP-1RAs) use and discontinuation, as well as attitudes to further injectable treatment intensification, among adults with type 2 diabetes (T2D).METHODS: Nineteen in-depth semi-structured...

Cite
Holmes-Truscott E, Schipp J, Dunning T, et al. 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabet Med. 2021;39(2):e14681doi: 10.1111/dme.14681.
Holmes-Truscott, E., Schipp, J., Dunning, T., Furler, J., Hagger, V., Holloway, E. E., Manski-Nankervis, J. A., Shaw, J. E., Skinner, T., & Speight, J. (2022). 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 39(2), e14681. https://doi.org/10.1111/dme.14681
Holmes-Truscott, Elizabeth, et al. "'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes." Diabetic medicine : a journal of the British Diabetic Association vol. 39,2 (2022): e14681. doi: https://doi.org/10.1111/dme.14681
Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis JA, Shaw JE, Skinner T, Speight J. 'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabet Med. 2022 Feb;39(2):e14681. doi: 10.1111/dme.14681. Epub 2021 Sep 04. PMID: 34465005.
Copy Download .nbib Format: NLM
Using Stereochemistry to Control Mechanical Properties in Thiol-Yne Click-Hydrogels.

Angewandte Chemie (International ed. in English)

Macdougall LJ, Pérez-Madrigal MM, Shaw JE, Worch JC, Sammon C, Richardson SM, Dove AP.
PMID: 34551190
Angew Chem Int Ed Engl. 2021 Dec 01;60(49):25856-25864. doi: 10.1002/anie.202107161. Epub 2021 Oct 28.

The stereochemistry of polymers has a profound impact on their mechanical properties. While this has been observed in thermoplastics, studies on how stereochemistry affects the bulk properties of swollen networks, such as hydrogels, are limited. Typically, changing the stiffness...

Cite
Macdougall LJ, Pérez-Madrigal MM, Shaw JE, et al. Using Stereochemistry to Control Mechanical Properties in Thiol-Yne Click-Hydrogels. Angew Chem Int Ed Engl. 2021;60(49):25856-25864doi: 10.1002/anie.202107161.
Macdougall, L. J., Pérez-Madrigal, M. M., Shaw, J. E., Worch, J. C., Sammon, C., Richardson, S. M., & Dove, A. P. (2021). Using Stereochemistry to Control Mechanical Properties in Thiol-Yne Click-Hydrogels. Angewandte Chemie (International ed. in English), 60(49), 25856-25864. https://doi.org/10.1002/anie.202107161
Macdougall, Laura J, et al. "Using Stereochemistry to Control Mechanical Properties in Thiol-Yne Click-Hydrogels." Angewandte Chemie (International ed. in English) vol. 60,49 (2021): 25856-25864. doi: https://doi.org/10.1002/anie.202107161
Macdougall LJ, Pérez-Madrigal MM, Shaw JE, Worch JC, Sammon C, Richardson SM, Dove AP. Using Stereochemistry to Control Mechanical Properties in Thiol-Yne Click-Hydrogels. Angew Chem Int Ed Engl. 2021 Dec 01;60(49):25856-25864. doi: 10.1002/anie.202107161. Epub 2021 Oct 28. PMID: 34551190.
Copy Download .nbib Format: NLM
Cardio-oncology: protecting the heart from curative breast cancer treatment.

Gland surgery

Upshaw JN.
PMID: 30175052
Gland Surg. 2018 Aug;7(4):350-365. doi: 10.21037/gs.2017.11.09.

Patients with breast cancer have higher rates of cardiovascular disease than age-matched controls. Anthracyclines and trastuzumab increase the risk of heart failure (HF) and radiation increases the risk of ischemic heart disease, valvular disease and HF. Older age, low...

Cite
Upshaw JN. Cardio-oncology: protecting the heart from curative breast cancer treatment. Gland Surg. 2018;7(4):350-365doi: 10.21037/gs.2017.11.09.
Upshaw, J. N. (2018). Cardio-oncology: protecting the heart from curative breast cancer treatment. Gland surgery, 7(4), 350-365. https://doi.org/10.21037/gs.2017.11.09
Upshaw, Jenica N. "Cardio-oncology: protecting the heart from curative breast cancer treatment." Gland surgery vol. 7,4 (2018): 350-365. doi: https://doi.org/10.21037/gs.2017.11.09
Upshaw JN. Cardio-oncology: protecting the heart from curative breast cancer treatment. Gland Surg. 2018 Aug;7(4):350-365. doi: 10.21037/gs.2017.11.09. PMID: 30175052; PMCID: PMC6107590.
Copy Download .nbib Format: NLM
The Role of Biomarkers to Evaluate Cardiotoxicity.

Current treatment options in oncology

Upshaw JN.
PMID: 32767198
Curr Treat Options Oncol. 2020 Aug 07;21(10):79. doi: 10.1007/s11864-020-00777-1.

OPINION STATEMENT: Moderate-level evidence suggests that cardiac troponin and natriuretic peptides are useful for risk stratification and early identification of anthracycline cardiotoxicity; however, many of these studies used older chemotherapy regimens, and thus, the applicability to current anthracycline treatment...

Cite
Upshaw JN. The Role of Biomarkers to Evaluate Cardiotoxicity. Curr Treat Options Oncol. 2020;21(10):79doi: 10.1007/s11864-020-00777-1.
Upshaw, J. N. (2020). The Role of Biomarkers to Evaluate Cardiotoxicity. Current treatment options in oncology, 21(10), 79. https://doi.org/10.1007/s11864-020-00777-1
Upshaw, Jenica N. "The Role of Biomarkers to Evaluate Cardiotoxicity." Current treatment options in oncology vol. 21,10 (2020): 79. doi: https://doi.org/10.1007/s11864-020-00777-1
Upshaw JN. The Role of Biomarkers to Evaluate Cardiotoxicity. Curr Treat Options Oncol. 2020 Aug 07;21(10):79. doi: 10.1007/s11864-020-00777-1. PMID: 32767198.
Copy Download .nbib Format: NLM
The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study.

JNCI cancer spectrum

Vajdic CM, MacInnis RJ, Canfell K, Hull P, Arriaga ME, Hirani V, Cumming RG, Mitchell P, Byles JE, Giles GG, Banks E, Taylor AW, Shaw JE, Magliano DJ, Marker J, Adelstein BA, Gill TK, Laaksonen MA.
PMID: 31360860
JNCI Cancer Spectr. 2018 Aug 28;2(3):pky033. doi: 10.1093/jncics/pky033. eCollection 2018 Jul.

BACKGROUND: Previous estimates of the colorectal cancer (CRC) burden attributed to behaviors have not considered joint effects, competing risk, or population subgroup differences.METHODS: We pooled data from seven prospective Australian cohort studies (n = 367 058) and linked them...

Cite
Vajdic CM, MacInnis RJ, Canfell K, et al. The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study. JNCI Cancer Spectr. 2018;2(3):pky033doi: 10.1093/jncics/pky033.
Vajdic, C. M., MacInnis, R. J., Canfell, K., Hull, P., Arriaga, M. E., Hirani, V., Cumming, R. G., Mitchell, P., Byles, J. E., Giles, G. G., Banks, E., Taylor, A. W., Shaw, J. E., Magliano, D. J., Marker, J., Adelstein, B. A., Gill, T. K., & Laaksonen, M. A. (2018). The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study. JNCI cancer spectrum, 2(3), pky033. https://doi.org/10.1093/jncics/pky033
Vajdic, Claire M, et al. "The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study." JNCI cancer spectrum vol. 2,3 (2018): pky033. doi: https://doi.org/10.1093/jncics/pky033
Vajdic CM, MacInnis RJ, Canfell K, Hull P, Arriaga ME, Hirani V, Cumming RG, Mitchell P, Byles JE, Giles GG, Banks E, Taylor AW, Shaw JE, Magliano DJ, Marker J, Adelstein BA, Gill TK, Laaksonen MA. The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study. JNCI Cancer Spectr. 2018 Aug 28;2(3):pky033. doi: 10.1093/jncics/pky033. eCollection 2018 Jul. PMID: 31360860; PMCID: PMC6649699.
Copy Download .nbib Format: NLM
A Case of Hæmophilia with Joint Lesions.

Bristol medico-chirurgical journal (1883)

Shaw JE.
PMID: 28897267
Bristol Med Chir J (1883). 1897 Sep;15(57):240-245.

No abstract available.

Cite
Shaw JE. A Case of Hæmophilia with Joint Lesions. Bristol Med Chir J (1883). 1897;15(57):240-245
Shaw, J. E. (1897). A Case of Hæmophilia with Joint Lesions. Bristol medico-chirurgical journal (1883), 15(57), 240-245.
Shaw, J E. "A Case of Hæmophilia with Joint Lesions." Bristol medico-chirurgical journal (1883) vol. 15,57 (1897): 240-245.
Shaw JE. A Case of Hæmophilia with Joint Lesions. Bristol Med Chir J (1883). 1897 Sep;15(57):240-245. PMID: 28897267; PMCID: PMC5050912.
Copy Download .nbib Format: NLM
Individualizing therapy: do we have the tools to do it?.

Journal of diabetes

Shaw JE, Bloomgarden ZT.
PMID: 25209957
J Diabetes. 2015 Jan;7(1):1-2. doi: 10.1111/1753-0407.12218. Epub 2014 Oct 20.

No abstract available.

Cite
Shaw JE, Bloomgarden ZT. Individualizing therapy: do we have the tools to do it?. J Diabetes. 2014;7(1):1-2doi: 10.1111/1753-0407.12218.
Shaw, J. E., & Bloomgarden, Z. T. (2015). Individualizing therapy: do we have the tools to do it?. Journal of diabetes, 7(1), 1-2. https://doi.org/10.1111/1753-0407.12218
Shaw, Jonathan E, and Bloomgarden, Zachary T. "Individualizing therapy: do we have the tools to do it?." Journal of diabetes vol. 7,1 (2015): 1-2. doi: https://doi.org/10.1111/1753-0407.12218
Shaw JE, Bloomgarden ZT. Individualizing therapy: do we have the tools to do it?. J Diabetes. 2015 Jan;7(1):1-2. doi: 10.1111/1753-0407.12218. Epub 2014 Oct 20. PMID: 25209957.
Copy Download .nbib Format: NLM
On-demand patterning of nanostructured pentacene transistors by scanning thermal lithography.

Advanced materials (Deerfield Beach, Fla.)

Shaw JE, Stavrinou PN, Anthopoulos TD.
PMID: 23138983
Adv Mater. 2013 Jan 25;25(4):552-8. doi: 10.1002/adma.201202877. Epub 2012 Nov 09.

Thermal scanning lithography is used to pattern semiconducting nanoribbon-like pentacene structures with ultrahigh spatial resolution onto arbitrary substrates in air. The method allows control of the pentacene crystal growth direction and domain-size distribution. By combining these quasi-one-dimensional nanoribbon-like structures...

Cite
Shaw JE, Stavrinou PN, Anthopoulos TD. On-demand patterning of nanostructured pentacene transistors by scanning thermal lithography. Adv Mater. 2012;25(4):552-8doi: 10.1002/adma.201202877.
Shaw, J. E., Stavrinou, P. N., & Anthopoulos, T. D. (2013). On-demand patterning of nanostructured pentacene transistors by scanning thermal lithography. Advanced materials (Deerfield Beach, Fla.), 25(4), 552-8. https://doi.org/10.1002/adma.201202877
Shaw, Joseph E, et al. "On-demand patterning of nanostructured pentacene transistors by scanning thermal lithography." Advanced materials (Deerfield Beach, Fla.) vol. 25,4 (2013): 552-8. doi: https://doi.org/10.1002/adma.201202877
Shaw JE, Stavrinou PN, Anthopoulos TD. On-demand patterning of nanostructured pentacene transistors by scanning thermal lithography. Adv Mater. 2013 Jan 25;25(4):552-8. doi: 10.1002/adma.201202877. Epub 2012 Nov 09. PMID: 23138983.
Copy Download .nbib Format: NLM
Metabolic syndrome-do we really need a new definition?.

Metabolic syndrome and related disorders

Shaw JE, Zimmet PZ, George K, Alberti MM.
PMID: 18370784
Metab Syndr Relat Disord. 2005;3(3):191-3. doi: 10.1089/met.2005.3.191.

No abstract available.

Cite
Shaw JE, Zimmet PZ, George K, et al. Metabolic syndrome-do we really need a new definition?. Metab Syndr Relat Disord. 2005;3(3):191-3doi: 10.1089/met.2005.3.191.
Shaw, J. E., Zimmet, P. Z., George, K., & Alberti, M. M. (2005). Metabolic syndrome-do we really need a new definition?. Metabolic syndrome and related disorders, 3(3), 191-3. https://doi.org/10.1089/met.2005.3.191
Shaw, Jonathan E, et al. "Metabolic syndrome-do we really need a new definition?." Metabolic syndrome and related disorders vol. 3,3 (2005): 191-3. doi: https://doi.org/10.1089/met.2005.3.191
Shaw JE, Zimmet PZ, George K, Alberti MM. Metabolic syndrome-do we really need a new definition?. Metab Syndr Relat Disord. 2005;3(3):191-3. doi: 10.1089/met.2005.3.191. PMID: 18370784.
Copy Download .nbib Format: NLM
Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)

Arneson LN, Upshaw JL, Howe CL, Felts SJ, Rodriguez M, Pease LR, Colonna M.
PMID: 20483797
J Immunol. 2010 Jun 01;184(11):6557. doi: 10.4049/jimmunol.1090036.

No abstract available.

Cite
Arneson LN, Upshaw JL, Howe CL, et al. Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells. J Immunol. 2010;184(11):6557doi: 10.4049/jimmunol.1090036.
Arneson, L. N., Upshaw, J. L., Howe, C. L., Felts, S. J., Rodriguez, M., Pease, L. R., & Colonna, M. (2010). Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells. Journal of immunology (Baltimore, Md. : 1950), 184(11), 6557. https://doi.org/10.4049/jimmunol.1090036
Arneson, Laura N, et al. "Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells." Journal of immunology (Baltimore, Md. : 1950) vol. 184,11 (2010): 6557. doi: https://doi.org/10.4049/jimmunol.1090036
Arneson LN, Upshaw JL, Howe CL, Felts SJ, Rodriguez M, Pease LR, Colonna M. Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells. J Immunol. 2010 Jun 01;184(11):6557. doi: 10.4049/jimmunol.1090036. PMID: 20483797; PMCID: PMC3384526.
Copy Download .nbib Format: NLM
Lateral Sclerosis of the Spinal Cord.

Bristol medico-chirurgical journal (1883)

Shaw JE.
PMID: 28896068
Bristol Med Chir J (1883). 1884 Dec;2(6):270-274.

No abstract available.

Cite
Shaw JE. Lateral Sclerosis of the Spinal Cord. Bristol Med Chir J (1883). 1884;2(6):270-274
Shaw, J. E. (1884). Lateral Sclerosis of the Spinal Cord. Bristol medico-chirurgical journal (1883), 2(6), 270-274.
Shaw, J E. "Lateral Sclerosis of the Spinal Cord." Bristol medico-chirurgical journal (1883) vol. 2,6 (1884): 270-274.
Shaw JE. Lateral Sclerosis of the Spinal Cord. Bristol Med Chir J (1883). 1884 Dec;2(6):270-274. PMID: 28896068; PMCID: PMC5029411.
Copy Download .nbib Format: NLM
Retention and Accumulation of Fæces.

Bristol medico-chirurgical journal (1883)

Shaw JE.
PMID: 28896072
Bristol Med Chir J (1883). 1885 Mar;3(7):43-47.

No abstract available.

Cite
Shaw JE. Retention and Accumulation of Fæces. Bristol Med Chir J (1883). 1885;3(7):43-47
Shaw, J. E. (1885). Retention and Accumulation of Fæces. Bristol medico-chirurgical journal (1883), 3(7), 43-47.
Shaw, J E. "Retention and Accumulation of Fæces." Bristol medico-chirurgical journal (1883) vol. 3,7 (1885): 43-47.
Shaw JE. Retention and Accumulation of Fæces. Bristol Med Chir J (1883). 1885 Mar;3(7):43-47. PMID: 28896072; PMCID: PMC5041173.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 95 entries